The Testosterone Trials: What the Results Mean for Healthcare Providers and for Science

The Testosterone Trials: What the Results Mean for Healthcare Providers and for Science Curr Sex Health Rep (2017) 9:290–295 https://doi.org/10.1007/s11930-017-0135-0 MEDICAL COMORBIDITIES (M MINER, S PARISH AND A GOLDSTEIN, SECTION EDITORS) The Testosterone Trials: What the Results Mean for Healthcare Providers and for Science Abraham Morgentaler Published online: 2 November 2017 Springer Science+Business Media, LLC 2017 Abstract Introduction Purpose of Review The purpose of this review was to assess the results of the Testosterone (T) Trials with regard to their The primary results of the Testosterone (T) Trials were pub- clinical and scientific implications. lished in the New England Journal of Medicine in February Recent Findings The T Trials investigated 1 year of T gel 2016 [1 ], followed by several subsequent reports for various versus placebo in 790 men 65 years and older with unequiv- individual component Trials [2–4, 5� ]. These results had been ocally low serum T concentrations (< 275 ng/dl). Safety mon- long anticipated, as until this study there had been no large itoring was performed for an additional year. Primary results controlled prospective study investigating testosterone in were improvement over placebo for sexual desire, sexual ac- men, leaving open questions about efficacy and safety that tivity, erection quality, physical activity, and mood. Vitality could not be answered http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Sexual Health Reports Springer Journals

The Testosterone Trials: What the Results Mean for Healthcare Providers and for Science

Loading next page...
 
/lp/springer_journal/the-testosterone-trials-what-the-results-mean-for-healthcare-providers-NiAcFupxI3
Publisher
Springer US
Copyright
Copyright © 2017 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Urology; Endocrinology
ISSN
1548-3584
eISSN
1548-3592
D.O.I.
10.1007/s11930-017-0135-0
Publisher site
See Article on Publisher Site

Abstract

Curr Sex Health Rep (2017) 9:290–295 https://doi.org/10.1007/s11930-017-0135-0 MEDICAL COMORBIDITIES (M MINER, S PARISH AND A GOLDSTEIN, SECTION EDITORS) The Testosterone Trials: What the Results Mean for Healthcare Providers and for Science Abraham Morgentaler Published online: 2 November 2017 Springer Science+Business Media, LLC 2017 Abstract Introduction Purpose of Review The purpose of this review was to assess the results of the Testosterone (T) Trials with regard to their The primary results of the Testosterone (T) Trials were pub- clinical and scientific implications. lished in the New England Journal of Medicine in February Recent Findings The T Trials investigated 1 year of T gel 2016 [1 ], followed by several subsequent reports for various versus placebo in 790 men 65 years and older with unequiv- individual component Trials [2–4, 5� ]. These results had been ocally low serum T concentrations (< 275 ng/dl). Safety mon- long anticipated, as until this study there had been no large itoring was performed for an additional year. Primary results controlled prospective study investigating testosterone in were improvement over placebo for sexual desire, sexual ac- men, leaving open questions about efficacy and safety that tivity, erection quality, physical activity, and mood. Vitality could not be answered

Journal

Current Sexual Health ReportsSpringer Journals

Published: Nov 2, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off